PVP Ventures Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

18.7%

Verhouding schuld/eigen vermogen

₹428.36m

Schuld

Rente dekkingsratio	n/a
Contant	₹75.02m
Aandelen	₹2.29b
Totaal verplichtingen	₹1.50b
Totaal activa	₹3.79b

Recente financiële gezondheidsupdates

Geen updates

PVP Ventures Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

PVP Ventures Limited to Report First Half, 2025 Results on Nov 12, 2024

Investor sentiment improves as stock rises 18%

PVP Ventures Limited, Annual General Meeting, Sep 27, 2024

Investor sentiment improves as stock rises 20%

First quarter 2025 earnings released: ₹0.09 loss per share (vs ₹0.16 loss in 1Q 2024)

New minor risk - Share price stability

PVP Ventures Limited to Report Q1, 2025 Results on Aug 12, 2024

PVP Ventures Limited to Report Q1, 2025 Results on Aug 12, 2024

Investor sentiment deteriorates as stock falls 19%

PVP Ventures Limited Appoints D Mahesh Company Secretary and Compliance Officer

Full year 2024 earnings released: EPS: ₹2.43 (vs ₹5.89 in FY 2023)

PVP Ventures Limited to Report Q4, 2024 Results on May 28, 2024

New minor risk - Market cap size

Insider recently sold ₹8.0m worth of stock

PVP Ventures Limited Announces Changes of Company Secretary / Compliance Officer

Third quarter 2024 earnings released: EPS: ₹2.59 (vs ₹0.35 loss in 3Q 2023)

PVP Ventures Limited Appoints K. Anand Kumar as Chief Financial Officer

Now 23% undervalued

PVP Ventures Limited to Report Q3, 2024 Results on Feb 12, 2024

PVP Ventures Limited Announces Resignation of Ramani Sabesan as Chief Financial Officer

Second quarter 2024 earnings released: ₹0.17 loss per share (vs ₹4.38 profit in 2Q 2023)

PVP Ventures Limited Announces Resignation of Derrin Ann George as Company Secretary

PVP Ventures Limited to Report Q2, 2024 Results on Nov 08, 2023

New minor risk - Share price stability

New minor risk - Shareholder dilution

PVP Ventures Limited Announces resignation of Nandakumar Subburaman as Non-Executive Independent Director of the Company with Effect from the Closure of Business Hours on August 24, 2023

PVP Ventures Limited (NSEI:PVP) agreed to acquire Humain Healthtech Pvt Itd for INR 230 million.

PVP Ventures Limited Announces Resignation of Sohrab Chinoy Kersasp as Non-Executive Independent Director

PVP Ventures Limited, Annual General Meeting, Sep 01, 2023

New minor risk - Revenue size

First quarter 2024 earnings released: ₹0.16 loss per share (vs ₹10.98 profit in 1Q 2023)

PVP Ventures Limited to Report Q1, 2024 Results on Aug 02, 2023

PVP Ventures Limited Appoints Mr. M Kumar as the Company Secretary & Compliance Officer

Full year 2023 earnings released: EPS: ₹9.75 (vs ₹2.44 loss in FY 2022)

PVP Ventures Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released

PVP Ventures Limited Appoints R Sabesan as Chief Financial Officer

PVP Ventures Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: EPS: ₹4.38 (vs ₹0.62 loss in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹4.38 (vs ₹0.62 loss in 2Q 2022)

PVP Ventures Limited to Report Q2, 2022 Results on Nov 11, 2022

PVP Ventures Limited, Annual General Meeting, Sep 30, 2022

PVP Ventures Limited Announces Resignation of Ms. S. Rukmani as Company Secretary and Compliance Officer

First quarter 2023 earnings released: EPS: ₹10.98 (vs ₹0.81 loss in 1Q 2022)

PVP Ventures Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings released: ₹3.89 loss per share (vs ₹2.31 loss in FY 2021)

PVP Ventures Limited to Report Q4, 2022 Results on May 25, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

First quarter 2022 earnings released: ₹0.81 loss per share (vs ₹0.92 loss in 1Q 2021)

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven